References
Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream.2007;129:1261–74.
Hausenloy DJ, Yellon DM. Survival kinases in ischaemic preconditioning and postconditioning. Cardiovasc Res. 2006;70:240–53.
Li L, Ross AH. Why is PTEN an important tumor suppressor? J Cell Biochem. 2007;102:1368–74.
Mocanu MM, Yellon DM. PTEN, the Achilles’ heel of myocardial ischaemia/reperfusion injury? Br J Pharmacol. 2007;150:833–8.
Mocanu MM, Field DC, Yellon DM. A potential role for PTEN in the diabetic heart. Cardiovasc Drugs Ther. 2006;20:319–21.
Siddall HK, Warrell CE, Yellon DM. Mocanu MM Ischaemia–reperfusion injury and cardioprotection: Investigating PTEN, the phosphatase that negatively regulates PI3K, using a congenital model of PTEN haploinsufficiency. Basic Res Cardiol. 2008 July 5 (in press)
Unoki M, Nakamura Y. Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway. Oncogene. 2001;20:4457–65.
Lin W, Kang UJ. Characterization of PINK1 processing, stability, and subcellular localization. J Neurochem. 2008;106:464–74.
Pridgeon JW, Olzmann JA, Chin LS, Li L. PINK1 Protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1. PLoS Biol. 2007;5:e172.
Deng H, Jankovic J, Guo Y, Xie W, Le W. Small interfering RNA targeting the PINK1 induces apoptosis in dopaminergic cells SH-SY5Y. Biochem Biophys Res Commun. 2005;337:1133–8.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Siddall, H.K., Warrell, C.E., Davidson, S.M. et al. Mitochondrial PINK1—A Novel Cardioprotective Kinase?. Cardiovasc Drugs Ther 22, 507–508 (2008). https://doi.org/10.1007/s10557-008-6136-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10557-008-6136-5